Global PCR and NGS-Based Molecular Diagnostics Market Research Report 2023

Report ID: 2005221 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Biomarker Discovery
        1.2.3 Blood Sample Testig
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Academics/Research Institutions
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2017-2028)
    2.2 PCR and NGS-Based Molecular Diagnostics Growth Trends by Region
        2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 PCR and NGS-Based Molecular Diagnostics Market Dynamics
        2.3.1 PCR and NGS-Based Molecular Diagnostics Industry Trends
        2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
        2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
        2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue
        3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
    3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
        3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2021
    3.5 PCR and NGS-Based Molecular Diagnostics Key Players Head office and Area Served
    3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
    3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
    4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
    5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2017-2028)
    6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022)
    6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2017-2028)
    7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022)
    7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2017-2028)
    9.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermofisher
        11.1.1 Thermofisher Company Detail
        11.1.2 Thermofisher Business Overview
        11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
        11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.1.5 Thermofisher Recent Development
    11.2 Illumine
        11.2.1 Illumine Company Detail
        11.2.2 Illumine Business Overview
        11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
        11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.2.5 Illumine Recent Development
    11.3 Paragon Genomics
        11.3.1 Paragon Genomics Company Detail
        11.3.2 Paragon Genomics Business Overview
        11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
        11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.3.5 Paragon Genomics Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
        11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Qiagen
        11.5.1 Qiagen Company Detail
        11.5.2 Qiagen Business Overview
        11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
        11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.5.5 Qiagen Recent Development
    11.6 Bioo Scientific
        11.6.1 Bioo Scientific Company Detail
        11.6.2 Bioo Scientific Business Overview
        11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
        11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.6.5 Bioo Scientific Recent Development
    11.7 Agilent
        11.7.1 Agilent Company Detail
        11.7.2 Agilent Business Overview
        11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
        11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.7.5 Agilent Recent Development
    11.8 Pillar Biosciences
        11.8.1 Pillar Biosciences Company Detail
        11.8.2 Pillar Biosciences Business Overview
        11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
        11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.8.5 Pillar Biosciences Recent Development
    11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
        11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
        11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
        11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
        11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
    11.10 iGen Technologies
        11.10.1 iGen Technologies Company Detail
        11.10.2 iGen Technologies Business Overview
        11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
        11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.10.5 iGen Technologies Recent Development
    11.11 Burning Rock
        11.11.1 Burning Rock Company Detail
        11.11.2 Burning Rock Business Overview
        11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
        11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
        11.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Biomarker Discovery
    Table 3. Key Players of Blood Sample Testig
    Table 4. Key Players of Others
    Table 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2017-2022)
    Table 9. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2023-2028)
    Table 11. PCR and NGS-Based Molecular Diagnostics Market Trends
    Table 12. PCR and NGS-Based Molecular Diagnostics Market Drivers
    Table 13. PCR and NGS-Based Molecular Diagnostics Market Challenges
    Table 14. PCR and NGS-Based Molecular Diagnostics Market Restraints
    Table 15. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players (2017-2022)
    Table 17. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2021)
    Table 18. Ranking of Global Top PCR and NGS-Based Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
    Table 22. Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2017-2022)
    Table 26. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2023-2028)
    Table 28. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2017-2022)
    Table 30. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2023-2028)
    Table 32. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Thermofisher Company Detail
    Table 43. Thermofisher Business Overview
    Table 44. Thermofisher PCR and NGS-Based Molecular Diagnostics Product
    Table 45. Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 46. Thermofisher Recent Development
    Table 47. Illumine Company Detail
    Table 48. Illumine Business Overview
    Table 49. Illumine PCR and NGS-Based Molecular Diagnostics Product
    Table 50. Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 51. Illumine Recent Development
    Table 52. Paragon Genomics Company Detail
    Table 53. Paragon Genomics Business Overview
    Table 54. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product
    Table 55. Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 56. Paragon Genomics Recent Development
    Table 57. Roche Company Detail
    Table 58. Roche Business Overview
    Table 59. Roche PCR and NGS-Based Molecular Diagnostics Product
    Table 60. Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 61. Roche Recent Development
    Table 62. Qiagen Company Detail
    Table 63. Qiagen Business Overview
    Table 64. Qiagen PCR and NGS-Based Molecular Diagnostics Product
    Table 65. Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 66. Qiagen Recent Development
    Table 67. Bioo Scientific Company Detail
    Table 68. Bioo Scientific Business Overview
    Table 69. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product
    Table 70. Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 71. Bioo Scientific Recent Development
    Table 72. Agilent Company Detail
    Table 73. Agilent Business Overview
    Table 74. Agilent PCR and NGS-Based Molecular Diagnostics Product
    Table 75. Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 76. Agilent Recent Development
    Table 77. Pillar Biosciences Company Detail
    Table 78. Pillar Biosciences Business Overview
    Table 79. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product
    Table 80. Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 81. Pillar Biosciences Recent Development
    Table 82. LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
    Table 83. LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
    Table 84. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product
    Table 85. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 86. LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
    Table 87. iGen Technologies Company Detail
    Table 88. iGen Technologies Business Overview
    Table 89. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product
    Table 90. iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 91. iGen Technologies Recent Development
    Table 92. Burning Rock Company Detail
    Table 93. Burning Rock Business Overview
    Table 94. Burning Rock PCR and NGS-Based Molecular DiagnosticsProduct
    Table 95. Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 96. Burning Rock Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global PCR and NGS-Based Molecular Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Biomarker Discovery Features
    Figure 3. Blood Sample Testig Features
    Figure 4. Others Features
    Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Academics/Research Institutions Case Studies
    Figure 8. Others Case Studies
    Figure 9. PCR and NGS-Based Molecular Diagnostics Report Years Considered
    Figure 10. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global PCR and NGS-Based Molecular Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region: 2021 VS 2028
    Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players in 2021
    Figure 14. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2021
    Figure 16. North America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 18. United States PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 22. Germany PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Region (2017-2028)
    Figure 30. China PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 38. Mexico PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 42. Turkey PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Thermofisher Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 45. Illumine Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 46. Paragon Genomics Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 47. Roche Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 48. Qiagen Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 49. Bioo Scientific Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 50. Agilent Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 51. Pillar Biosciences Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 52. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 53. iGen Technologies Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 54. Burning Rock Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock
Frequently Asked Questions
PCR and NGS-Based Molecular Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PCR and NGS-Based Molecular Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PCR and NGS-Based Molecular Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Buna-N Rubber

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More